MedPath

THEODOR BILHARZ RESEARCH INSTITUTE

🇪🇬Egypt
Ownership
-
Employees
-
Market Cap
-
Website
http://www.tbri.sci.eg/

Clinical Trials

38

Active:1
Completed:29

Trial Phases

4 Phases

Phase 2:2
Phase 3:3
Phase 4:10
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials

Not Applicable
16 (51.6%)
Phase 4
10 (32.3%)
Phase 3
3 (9.7%)
Phase 2
2 (6.5%)

S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis

Completed
Conditions
S100A8
Serum
Urine
Biomarker
Lupus
Nephritis
First Posted Date
2025-03-12
Last Posted Date
2025-05-21
Lead Sponsor
Theodor Bilharz Research Institute
Target Recruit Count
70
Registration Number
NCT06872138
Locations
🇪🇬

Theodor Bilharz Research Institute, Giza, Egypt

New Technique of Pancreaticojejunostomy During Whipple Operation

Phase 4
Completed
Conditions
Periampullary Carcinoma Resectable
Pancreatic Tumors
Duodenal Neoplasms
First Posted Date
2024-10-08
Last Posted Date
2024-10-08
Lead Sponsor
Theodor Bilharz Research Institute
Target Recruit Count
48
Registration Number
NCT06630910
Locations
🇪🇬

Theodor Bilharz Research Institute, Giza, Egypt

Using Indocyanine Green (ICG) to Outline Biliary Tree During Laparoscopic Cholecystectomy

Phase 4
Completed
Conditions
Chronic Calculous Cholecystitis
Laparoscopic Cholecystectomy
Interventions
Drug: Indocyanine Green Drug
First Posted Date
2024-10-07
Last Posted Date
2024-10-07
Lead Sponsor
Theodor Bilharz Research Institute
Target Recruit Count
60
Registration Number
NCT06629415
Locations
🇪🇬

Theodor Bilharz Research Institute, Giza, Egypt

Dexmedetomidine for Attenuation of Pressor Response

Phase 4
Completed
Conditions
Pressor Response
Interventions
First Posted Date
2024-09-11
Last Posted Date
2024-09-11
Lead Sponsor
Theodor Bilharz Research Institute
Target Recruit Count
60
Registration Number
NCT06592027
Locations
🇪🇬

Theodor Bilharz Research institute, Giza, Egypt

Postoperative Hypoxemia in Obese Patients

Not Applicable
Completed
Conditions
Atelectasis, Postoperative Pulmonary
Bariatric Surgery
First Posted Date
2024-09-10
Last Posted Date
2024-09-10
Lead Sponsor
Theodor Bilharz Research Institute
Target Recruit Count
170
Registration Number
NCT06589011
Locations
🇪🇬

Theodor Bilharz Research institute, Giza, Cairo, Egypt

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.